Viewing Study NCT00513669


Ignite Creation Date: 2025-12-24 @ 10:52 PM
Ignite Modification Date: 2025-12-25 @ 8:21 PM
Study NCT ID: NCT00513669
Status: COMPLETED
Last Update Posted: 2013-03-15
First Post: 2007-08-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania
Sponsor: Swiss Tropical & Public Health Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module